Egypt Captivates World with Golden Pharaoh Parade
Twenty-two pharaoh mummies walked the streets of Cairo on Saturday evening in a stunning royal procession from the Egyptian Museum on Tahrir Square to the new National Museum of Egyptian Civilization (NMEC) in Fustat. The event marked the official launch of NMEC.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210403005008/en/
Egypt Captivates World with Golden Pharaoh Parade (Photo: AETOSWire)
Against the backdrop of fireworks, the mummies – 18 kings and four queens – travelled in order of age on purpose-built gold-colored pharaonic chariots, equipped with an air ride suspension system to absorb vibrations, and bearing the name of their occupants in Arabic, English, and hieroglyphics. Seqenenre Tao II, who reigned over Upper Egypt around 1,600 BCE, led the parade, while Ramses IX, who ruled in the 12th century BCE, brought up the rear. In line with strict international standards for the transport of artifacts, the royal remains were placed in state-of-the-art sterile display cases to guarantee their immaculate preservation.
Accompanying the mummies were 60 motorcycles, 150 horses, and a pharaonic music ensemble conducted by renowned Egyptian maestro Nader Abbassi. The procession commenced with a 21-gun salute, circled the obelisk at the nearby Tahrir Square, and then proceeded along the Nile to NMEC, where Egyptian President Abdel Fattah El-Sisi personally welcomed the mummies to their new permanent home in Fustat, the National Museum of Egyptian Civilization. The 40-minute parade drew participation of 12 Egyptian celebrities, being broadcast by 200+ global TV channels.
The priceless artifacts will spend the next two weeks in NMEC’s laboratory, where they will be prepared for installation inside the Royal Mummies Hall, modeled on the Valley of the Kings. The Royal Mummies Hall will open to visitors on April 18, coinciding with World Heritage Day.
To promote its launch, NMEC offers a 50 percent discount on entry ticket prices to the Central Exhibition Hall for all visitors from April 4 to 17. In addition, representatives of local and international media have the opportunity to photograph and film the artifacts inside the Central Exhibition Hall for free on April 4 and 5.
Overlooking Ain Al Sira in the heart of the historical city of Fustat near the Babylon Fortress, NMEC is one of the largest and most important archeology museums in the world, and the first to span the entirety of the Egyptian civilization.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210403005008/en/
Contact information
APCO Worldwide
Shady ElGohary
Account Director, +971552424797
selgohary@apcoworldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
REJO MULTI Unveiled at InterTabac 2025, Featuring Dual-Heating and Cross-Brand Compatibility19.9.2025 11:00:00 EEST | Press release
REJO, a global heat-not-burn (HNB) pioneer, officially unveiled REJO MULTI device at InterTabac 2025 as one of the exhibition’s most anticipated products. The device introduces a dual-heating system that pairs AirFlow and Round Heating technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250919713971/en/ REJO MULTI Product Launch Event “REJO MULTI represents a major step forward in HNB technology,” said Loic Li, the Global Sales Director of REJO. “Its open compatibility allows users to explore multiple brands and flavors with a single device, while our dual-heating system ensures even heating, enhanced aroma delivery, and consistent nicotine satisfaction.” “Our goal with REJO MULTI is to empower users with choice and flexibility, while providing retailers and partners with an innovative, market-ready product that elevates the smoking alternative experience,” said Tibor Braun, the Western Europe Manager of REJO. “This
SMBC Group and Jefferies Significantly Expand Their Global Strategic Alliance19.9.2025 11:00:00 EEST | Press release
Jefferies Financial Group, Inc. (NYSE: JEF) (“Jefferies”) and Sumitomo Mitsui Financial Group, Inc. (NYSE: SMFG) (“SMFG”), Sumitomo Mitsui Banking Corporation (“SMBC”), and SMBC Nikko Securities Inc. (“SMBC Nikko”) (collectively, “SMBC Group”) announced today that they are significantly expanding their Global Strategic Alliance. SMBC Group and Jefferies initially entered into a Strategic Alliance in 2021 to collaborate on future corporate and investment banking business opportunities. In 2023, the Alliance was expanded to enhance collaboration across M&A, equity and debt capital markets, with a particular focus on investment grade clients in the U.S. SMBC Group and Jefferies subsequently added Memoranda of Understanding to expand their alliance to the EMEA region, Canada, Asia and Australia, as well as to expand the scope of Joint Coverage initiatives to larger global sponsors, pre-IPO companies, and sub-investment grade corporate clients. Today, Jefferies and SMBC Group announce the n
CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release
Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom